Amphiphysin I Is Associated with Coated Endocytic Intermediates and Undergoes Stimulation-dependent Dephosphorylation in Nerve Terminals*
- From the Department of Cell Biology and the Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06510
Abstract
Amphiphysin I is an abundant presynaptic protein that interacts via its COOH-terminal src homology 3 (SH3) domain with the GTPase dynamin I and the inositol-5-phosphatase synaptojanin. Both dynamin I and synaptojanin I have a putative role in synaptic vesicle recycling and undergo rapid dephosphorylation in rat brain synaptosomes stimulated to secrete by a depolarizing stimulus. We show here that amphiphysin I also undergoes constitutive phosphorylation and stimulationdependent dephosphorylation. Dephosphorylation of amphiphysin I requires extracellular Ca2+ and is unaffected by pretreatment of synaptosomes with tetanus toxin. Thus, Ca2+ influx, but not synaptic vesicle exocytosis, is required for dephosphorylation. Dephosphorylation of amphiphysin I, like dephosphorylation of dynamin I and synaptojanin I, is inhibited by cyclosporin A and FK-506 (0.5 μm), two drugs that specifically block the Ca2+/calmodulin-dependent phosphatase 2B calcineurin, but not by okadaic acid (1 μm), which blocks protein phosphatases 1 and 2B. We also show by immunogold electron microscopy immunocytochemistry that amphiphysin I is localized in the nerve terminal cytomatrix and is partially associated with endocytic intermediates. These include the clathrin-coated buds and dynamin-coated tubules, which accumulate in nerve terminal membranes incubated in the presence of guanosine 5′-3-O-(thio)triphosphate. These data support the hypothesis that amphiphysin I, dynamin I, and synaptojanin I are physiological partners in some step(s) of synaptic vesicle endocytosis. We hypothesize that the parallel Ca2+-dependent calcineurin-dependent dephosphorylation of amphiphysin I and of its two major binding proteins is part of a process that primes the nerve terminal for endocytosis in response to a burst of exocytosis.
Footnotes
-
↵* This work was supported by grants from the Human Frontiers Science Program and the Donahue Foundation, National Institutes of Health Grants NS36251 and CA46128 (to P. D. C.), and by a fellowship from the Deutsche Forschungsgemeinschaft (to R. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵‡ Present address: Dept. of Biochemistry, Medizinische Hochschule Hannover, OE4310, D-30623 Hannover, Germany.
-
↵§ To whom correspondence should be addressed: Dept. of Cell Biology, Howard Hughes Medical Institute, Yale University School of Medicine, 295 Congress Ave., New Haven, CT 06510. Tel.: 203-737-4465; Fax: 203-737-4436; E-mail: pietro.decamilli{at}yale.edu.
-
↵1 The abbreviations used are: SH3, src homology 3; ΔCnA, recombinant calcineurin A lacking the autoinhibitory and calmodulin-binding domains; PAGE, polyacrylamide gel electrophoresis; MOPS, 4-morpholinepropanesulfonic acid; GTPγS, guanosine 5′-3-O-(thio)triphosphate; ATPγS, adenosine 5′-O-(thiotriphosphate).
-
- Received June 19, 1997.
- Revision received August 22, 1997.











